[Amended] Subscription results of rights offering or equity-linked bonds (voluntary)

What happened

Amendment report

Amendment date: 2026-08-12

1. Disclosure document subject to amendment Subscription results of rights offering or equity-linked bonds, etc. (voluntary disclosure)

2. Date of filing of the disclosure document subject to amendment 2026-08-11

3. Reason for amendment Amendment due to an error in the stated subscription rate

4. Amended items Amended item: Before amendment / After amendment "7. Other matters for reference in investment decisions - 2-2. Details of general public offering subscription - 6) Subscription competition rate": 419.03% / "7. Other matters for reference in investment decisions - 2-2. Details of general public offering subscription - 6) Subscription rate": 41,903.31%

Subscription results of rights offering or equity-linked bonds, etc. (voluntary disclosure)

1. Type of securities Registered common shares

2. Issuance method Shareholder-allocated rights offering

3. Subscription target General public offering subscribers (including subscriptions by high-risk high-return investment trusts and venture company investment trusts)

4. Subscription date 2026-08-11

5. Subscription results Planned number of shares to be issued (shares): 8,500,000 Number of shares subscribed (shares): 319,445,286 Cumulative number of shares subscribed (shares): 327,182,947 Subscription rate (%): 3,849.21

6. Method of handling fractional shares and forfeited shares -

7. Other matters for reference in investment decisions 1. The above "4. Subscription date" is the end date of the general public offering subscription period. (General public offering subscription period: August 10, 2026 - August 11, 2026) 2. Details of subscription results 2-1. Details of existing shareholder subscription 1) Number of shares offered: 8,500,000 shares 2) Number of shares subscribed under preemptive rights: 7,142,080 shares 3) Number of shares subscribed in excess: 595,581 shares (excess subscription allotment ratio: 100%) 4) Subscription rate: 91.03% 2-2. Details of general public offering subscription 1) Number of shares offered: 762,339 shares 2) Number of shares subscribed by general investors: 308,642,218 shares (competition rate: 674.77:1) 3) Number of shares subscribed by high-risk high-return investment trusts: 8,763,390 shares (competition rate: 114.95:1) 4) Number of shares subscribed by venture company investment trusts: 2,039,678 shares (competition rate: 8.92:1) 5) Total number of shares subscribed under general offering: 319,445,286 shares 6) Subscription rate: 41,903.31% 3. The "planned number of shares to be issued" in the above "5. Subscription results" is the total number of shares to be issued through this rights offering. 4. The "number of shares subscribed" in the above "5. Subscription results" is the number of shares subscribed in the general public offering. 5. The "cumulative number of shares subscribed" in the above "5. Subscription results" is the simple sum of the existing shareholder subscription and the general public offering subscription. 6. Future schedule 1) Date of refund and share payment: August 13, 2026 2) Expected listing date of new shares: August 28, 2026

* Related disclosures 2026-08-07 Subscription results of rights offering or equity-linked bonds, etc. (voluntary disclosure) 2026-08-03 Prospectus 2026-08-03 Securities registration statement (equity securities) 2026-08-03 Rights offering decision (shareholder allocation with forfeited shares to general public offering) 2026-08-03 Final issue price of rights offering confirmed 2026-07-15 New listing of preemptive rights certificates (Penetrium Bioscience 10R) 2026-06-26 Prospectus 2026-06-26 Securities registration statement (equity securities) 2026-06-26 First issue price of rights offering determined 2026-06-26 Rights offering decision (shareholder allocation with forfeited shares to general public offering) 2026-06-11 Securities registration statement (equity securities) 2026-06-11 Rights offering decision (shareholder allocation with forfeited shares to general public offering) 2026-05-27 Securities registration statement (equity securities) 2026-05-27 Rights offering decision (shareholder allocation with forfeited shares to general public offering) 2026-04-30 Securities registration statement (equity securities) 2026-04-30 Rights offering decision (shareholder allocation with forfeited shares to general public offering)